Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls

Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls

Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs)...

Full description

Bibliographic Details
Main Authors: Ali Shalash, Mohamed Salama, Marianne Makar, Tamer Roushdy, Hanan Hany Elrassas, Wael Mohamed, Mahmoud El-Balkimy, Mohamed Abou Donia
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Neurology
Subjects:
autoantibodies
biomarkers
α synuclein
Parkinson’s disease
Alzheimer’s disease
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2017.00720/full

Internet

http://journal.frontiersin.org/article/10.3389/fneur.2017.00720/full

Similar Items